Join
Live feed
·
PRReleasevia Quantisnow
Humacyte Inc. logo

Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access

ByQuantisnow·Wall Street's wire, on your screen.
HUMA· Humacyte Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HUMA (Humacyte Inc.) and more on Quantisnow.